Norway· NO-ID_F033CD23-1CB3-469F-A012-B5FD2E0E0181
Enflonsia
A clesrovimab product containing clesrovimab, registered in Norway by Merck Sharp & Dohme B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Clesrovimab is registered in 11 of 19 countries.
Countries holding a registration under ATC J06BD10 (clesrovimab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Clesrovimab · ATC J06BD10
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Clesrovimab
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Norway (NO)
- ATC code
- J06BD10
- ATC class
- Clesrovimab
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_F033CD23-1CB3-469F-A012-B5FD2E0E0181
- no_varenummer4790270.7NOK 8629.6
- gtin0191778025514
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Clesrovimab in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaENFLONSIAMerck Sharp & Dohme B.V., Haarlem
- BelgiumEnflonsia 105 mgMerck Sharp & Dohme
- SpainENFLONSIA 105 MG SOLUCION INYECTABLE EN JERINGA PRECARGADAMerck Sharp & Dohme B.V.
- IcelandEnflonsiaMerck Sharp & Dohme B.V.*
- PolandEnflonsiaMerck Sharp & Dohme B.V.
- SwedenEnflonsia 105 mg Injektionsvätska, lösning i förfylld sprutaMerck Sharp & Dohme BV
- SwitzerlandEnflonsia
- FinlandEnflonsiaMerck Sharp & Dohme B.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Enflonsia
- Liechtenstein · Enflonsia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2e24ec5b-dcff-467f-bdb6-26bead3405fd GET /v1/drugs/2e24ec5b-dcff-467f-bdb6-26bead3405fd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning i ferdigfylt sprøyte",
"source": "fest",
"status": "A",
"atc_name": "Klesrovimab",
"merkevare_id": "ID_F033CD23-1CB3-469F-A012-B5FD2E0E0181",
"name_form_strength": "Enflonsia inj, oppl 105 mg",
"prescription_group": "C"
}See everything about clesrovimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.